Examining the effectiveness of antipsychotic medication in first-episode psychosis

被引：19
|
作者：
Taylor, Mark
Cavanagh, Jonathan [1 ]
Hodgson, Richard
Tiihonen, Jari [2 ,3 ]
机构：
[1] So Gen Hosp, Glasgow G51 4TF, Lanark, Scotland
[2] Univ Kuopio, Niuvanniemi Hosp, Dept Forens Psychiat, FIN-70211 Kuopio, Finland
[3] Natl Inst Hlth & Welf, Helsinki, Finland
来源：
JOURNAL OF PSYCHOPHARMACOLOGY | 2012年 / 26卷 / S5期
关键词：
Antipsychotic; effectiveness; first-episode psychosis; RANDOMIZED CONTROLLED-TRIAL; ATYPICAL ANTIPSYCHOTICS; 2ND-GENERATION ANTIPSYCHOTICS; SCHIZOAFFECTIVE DISORDER; CHRONIC-SCHIZOPHRENIA; DOUBLE-BLIND; DRUGS; OLANZAPINE; METAANALYSIS; RISPERIDONE;
D O I：
10.1177/0269881112439252
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
The regular use of antipsychotic medication is known to improve overall outcomes and diminish risk of relapse, but applying the results of randomised controlled trials (RCTs) into routine clinical practice is not always straightforward. Furthermore, psychiatrists, service users and policy makers can have trouble keeping up with the burgeoning and, at times, conflicting results from research trials, meta-analysis and systematic reviews. In this paper we examine the differences between efficacy and effectiveness trials with regard to antipsychotic medication with a focus on first-episode psychosis, after reviewing the relative contribution of antipsychotic medication to outcomes in schizophrenia.
引用
收藏
页码：27 / 32
页数：6
相关论文
共 50 条
  • [41] A review of second-generation antipsychotic discontinuation in first-episode psychosis
    Miller, Brian J.
    JOURNAL OF PSYCHIATRIC PRACTICE, 2008, 14 (05) : 289 - 300
  • [42] Immunomodulatory effects of antipsychotic treatment on gene expression in first-episode psychosis
    Mantere, Outi
    Trontti, Kalevi
    Garcia-Gonzalez, Judit
    Balcells, Ingrid
    Saarnio, Suvi
    Mantyla, Teemu
    Lindgren, Maija
    Kieseppa, Tuula
    Raij, Tuukka
    Honkanen, Jarno K.
    Vaarala, Outi
    Hovatta, Iiris
    Suvisaari, Jaana
    JOURNAL OF PSYCHIATRIC RESEARCH, 2019, 109 : 18 - 26
  • [43] Profiling of lipidomics before and after antipsychotic treatment in first-episode psychosis
    Liisa Leppik
    Madis Parksepp
    Sven Janno
    Kati Koido
    Liina Haring
    Eero Vasar
    Mihkel Zilmer
    European Archives of Psychiatry and Clinical Neuroscience, 2020, 270 : 59 - 70
  • [44] A 2-year audit of antipsychotic use in first-episode psychosis
    Matthiasson, P
    Power, P
    McGuire, G
    SCHIZOPHRENIA RESEARCH, 2004, 70 (01) : 139 - 139
  • [45] Profiling of lipidomics before and after antipsychotic treatment in first-episode psychosis
    Leppik, Liisa
    Parksepp, Madis
    Janno, Sven
    Koido, Kati
    Haring, Liina
    Vasar, Eero
    Zilmer, Mihkel
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2020, 270 (01) : 59 - 70
  • [46] White Matter Changes Associated with Antipsychotic Treatment in First-Episode Psychosis
    Philip R Szeszko
    Delbert G Robinson
    Toshikazu Ikuta
    Bart D Peters
    Juan A Gallego
    John Kane
    Anil K Malhotra
    Neuropsychopharmacology, 2014, 39 : 1324 - 1331
  • [47] Isolating the impact of antipsychotic medication on metabolic health: Secondary analysis of a randomized controlled trial of antipsychotic medication versus placebo in antipsychotic medication naive first-episode psychosis (the STAGES study)
    O'Donoghue, Brian
    Allott, Kelly
    Harrigan, Susy
    Scalzo, Franco
    Ward, Janine
    Mallawaarachchi, Sumudu
    Whitson, Sarah
    Baldwin, Lara
    Graham, Jessica
    Mullen, Edward
    MacNeil, Craig
    Alexander, Dylan
    Wood, Stephen J.
    Berk, Michael
    Alvarez-Jimenez, Mario
    Thompson, Andrew
    Fornito, Alex
    Yuen, Hok Pan
    Nelson, Barnaby
    Francey, Shona M.
    McGorry, Patrick
    EARLY INTERVENTION IN PSYCHIATRY, 2023, 17 (06) : 597 - 607
  • [48] Psychosocial treatment, antipsychotic postponement, and low-dose medication strategies in first-episode psychosis: A review of the literature
    Bola, John R.
    Lehtinen, Klaus
    Cullberg, Johan
    Ciompi, Luc
    PSYCHOSIS-PSYCHOLOGICAL SOCIAL AND INTEGRATIVE APPROACHES, 2009, 1 (01): : 4 - 18
  • [49] Dorsal striatial hypoconnectivity predicts antipsychotic medication treatment response in first-episode psychosis and unmedicated patients with schizophrenia
    Nelson, Eric A.
    Kraguljac, Nina, V
    Maximo, Jose O.
    Armstrong, William
    Lahti, Adrienne C.
    BRAIN AND BEHAVIOR, 2022, 12 (11):
  • [50] Psychosocial treatment, antipsychotic postponement, and low-dose medication strategies in first-episode psychosis: A review of the literature
    Bola, John R.
    Lehtinen, K.
    Cullberg, J.
    Ciompi, L.
    PSYCHOSIS-PSYCHOLOGICAL SOCIAL AND INTEGRATIVE APPROACHES, 2009, 1 : S75 - S76
12345